University Of Tartu

4 trials 1 recruiting Academic / non-commercial Merged from 2 name variants

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

1 Recruiting

2 Completed trials

2 Countries active

6 Unique IMPs

100% Results reported

Phase II

Phase IV

Phase II: 1 Phase IV: 3

Oversight events:

1 serious breach across 1 trial

View oversight register →

100%

2 of 2 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Progressive multiple sclerosis 1

Top IMPs

All trials

4 total

Effect on the tolerability of semaglutide in overweight adults without diabetes Pending

2025-524612-11-00 Phase IV 1 country
A clinical proof-of-concept study to reduce smoldering inflammation in progressive MS Recruiting

2024-517336-21-00 Phase II 1 country
The Pragmatic EE-PRS Trial assessing Polygenic Risk Driven Statin Therapy for Cardiovascular Disease Prevention Ended

2024-513424-42-01 Phase IV 1 country
The efficacy of aprepitant for the prevention of postoperative nausea and vomiting after bariatric surgery. Ended

2023-508849-40-00 Phase IV 1 country APREPITANT

Showing 1–4 of 4 trials

← All sponsors A–Z